Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Obinutuzumab
Acalabrutinib
Patient Power
CLL Society
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Cancer.gov